Presented
by

Presented by Oxford Global

Discover PLUS Pass

Industry News

The Industry News page consists of Industry Spotlights, Pre-Event Newsletters, Post-Event Reports, Whitepapers and Vendor News.

Industry Spotlight
Targeting Novel E3 Ubiquitin Ligases: Carles Galdeano, Professor, University of Barcelona
We discuss working on PROTACs, targeting novel E3 ubiquitin ligases, and Dr Galdeano's spin out Oniria Therapeutics.
Edited by Tom Cohen |
01 December 2023
Targeted Protein Degradation
Industry Spotlight
Spheroids, Assembloids Could Unlock High Throughput Screening of Neuro Drugs
These spheroids can mimic different sections of the human brain based on their cell-type composition, and promisingly could enable high-throughput screening of neurology drugs.
Edited by Tom Cohen |
29 November 2023
Organ Modelling Discovery
Industry Spotlight
Talking TPD with Ben Cross, CTO and Head of Platform at PhoreMost
Delving into PhoreMost's role in targeted protein degradation, the innovation behind the SITESEEKER platform, and the challenges and breakthroughs in the dynamic field of drug discovery.
Edited by Tom Cohen |
22 November 2023
Targeted Protein Degradation
Whitepaper
Pivot Park Screening Centre: We Help You to Accelerate Drug Discovery
Are you looking for lead candidate compounds for your target or cellular phenotype, and do you want your drug discovery program to be more efficient, both in terms of time and cost?
Edited by Tom Cohen |
16 November 2023
Target Based Discovery
Industry Spotlight
Interview with Nicolas Vachicouras, CEO, Neurosoft Bioelectronics: Subdural Brain Interfaces
Talking with Nicolas Vachicouras, CEO of Neurosoft Bioelectronics about their subdural brain interface and its inaugural clinical testing for recording the human brain in the context of an epilepsy resective surgery.
Edited by Tom Cohen |
01 November 2023
Neuroscience Discovery
Industry Spotlight
Vascular Organoids used to Model the Impact of COVID-19 on Circulation
Researchers have used vascular organoids to look at the impact of SARS-CoV-2 on blood circulation, which has led to the discovery of a potential therapeutic target.
Edited by Tom Cohen |
26 October 2023
Organ Modelling Discovery
Industry Spotlight
Biophysical Tools for the Design and Development of PROTACs
Protein degradation has emerged as a promising new field of therapeutics. What are biophysical tools are employed for the characterisation of these drugs?
Edited by Tom Cohen |
19 October 2023
Medicinal Chemistry & Drug Design
Industry Spotlight
Cerebral Organoids: the Sci-Fi Organ Model Explaining our Brains
These miniature brain replicas, cultivated from patient-derived stem cells, provide a unique window into the intricacies of brain development.
Edited by Tom Cohen |
25 September 2023
Organ Modelling Discovery
Industry Spotlight
Nasal Spray Shows Remarkable Efficacy in Easing Social Anxiety: Vistagen's Fasedienol Promises New Hope
Positive phase III results propel innovative pherine nasal spray as potential game-changer for millions struggling with social anxiety disorder. Vistagen's novel mechanism of action sparks optimism after previous setback.
Edited by Tom Cohen |
08 August 2023
Neuroscience Discovery
Industry Spotlight
Prothena and Evotec Score Major Deals with Bristol Myers Squibb for Neuroscience Breakthroughs
Prothena will receive $55 million to license its clinical Alzheimer's drug candidate, while Evotec will receive $40 million for its late-stage clinical programs.
Edited by Tom Cohen |
14 July 2023
Neuroscience Discovery
> See All Discovery Content

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.